COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 23:00, il y a 8 mois 3 jours Viemed Healthcare Announces Second Quarter 2025 Financial Results Viemed Healthcare, Inc. reports Q2 2025 financial results with net revenues reaching $63.1 million and net income increasing by 115.1% to $3.2 million. The company's operational highlights and updated full year guidance are discussed Financial Results Updated Guidance Net Revenues Q2 2025 Viemed Healthcare
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:30, il y a 8 mois 3 jours Telkom South Africa Successfully Modernizes its Legacy Business Support Systems with Amdocs’ Cloud-Native Customer Experience Suite Amdocs announces successful BSS transformation with Telkom South Africa enhancing customer experience and innovation for 25 million subscribers Innovation Amdocs Customer Experience Telkom South Africa BSS Transformation
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:20, il y a 8 mois 3 jours A1 Macedonia Selects Amdocs to Modernize its Monetization Platforms A1 Macedonia partners with Amdocs to modernize monetization platforms, enhancing operational efficiencies and customer experiences. Amdocs to deploy billing, charging, and product catalog solutions for converged and cloud-ready foundation Amdocs Customer Experience Monetization Modernization A1 Macedonia
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:15, il y a 8 mois 3 jours Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength Amrize delivers solid second quarter results showing strength in business and market positions. Launches ASPIRE program for synergies and accelerates margin expansion Financial Results Market Growth Amrize ASPIRE Program Investment-grade Balance Sheet
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:15, il y a 8 mois 3 jours Kingstone Stockholders Approve Company Proposals at 2025 Annual Meeting Kingstone Companies, Inc. announces updated board composition following annual stockholders meeting. Pranav Pasricha elected to the Board Insurance Kingstone Companies Inc. Annual Meeting Board Composition Pranav Pasricha
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:12, il y a 8 mois 3 jours Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth Zomedica Corp. reports record year-over-year revenue for 18th straight quarter, with 14% growth in Q2 2025 driven by Diagnostic and Consumable segments Financial Results Zomedica Corp. Record Revenue Veterinary Health Growth
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:10, il y a 8 mois 3 jours Consumer Cellular Expands Strategic Collaboration with Amdocs to Accelerate AI-Driven MVNE Capabilities Amdocs expands agreement with Consumer Cellular to enhance MVNE platform with AI & Data Platform, Customer Experience Insights, and amAIz Suite for improved onboarding, operations, and customer experiences Amdocs AI Customer Experiences Consumer Cellular MVNE Platform
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:10, il y a 8 mois 3 jours Gladstone Commercial Corporation Reports Results for the Second Quarter Ended June 30, 2025 Gladstone Commercial Corporation reports financial results for Q2 2025 including FFO and Core FFO financial measures. Visit the website for detailed information Financial Results Gladstone Commercial Corporation FFO Core FFO Q2 2025
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:05, il y a 8 mois 3 jours FRP Holdings, Inc. Reports Fiscal 2025 Second Quarter Results FRP Holdings, Inc. reports 72% decrease in Net Income for Q2 2025, along with increases in pro rata NOI for Multifamily and Mining segments. Company's focus on industrial business and new projects highlighted Growth Strategy Financial Results Real Estate Industrial Segment FRP Holdings
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 22:05, il y a 8 mois 3 jours Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update Protagonist Therapeutics reports NDA submission for icotrokinra for PsO treatment, Phase 2b trial for icotrokinra in UC, VERIFY trial data of rusfertide in PV, and financial results for Q2 2025 Financial Results Protagonist Therapeutics Psoriasis Icotrokinra Phase 3 VERIFY Trial
Publié le 09/04/2026 à 20:00, il y a 3 heures 37 minutes SMTPC - Communiqué sur le Chiffre d'affaires du 1er trimestre 2026
Publié le 09/04/2026 à 18:35, il y a 5 heures 2 minutes Mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 30 avril 2026
Publié le 09/04/2026 à 18:35, il y a 5 heures 2 minutes Availability of proxy documents for the Combined General Meeting of April 30, 2026
Publié le 09/04/2026 à 23:15, il y a 22 minutes Digi Power X Enters into Amended and Restated Sales Agreement
Publié le 09/04/2026 à 23:00, il y a 37 minutes Apex Critical Metals to Attend Critical Materials Conference: Aerospace & Defence in Washington, DC
Publié le 09/04/2026 à 19:15, il y a 4 heures 22 minutes Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Publié le 09/04/2026 à 16:00, il y a 7 heures 37 minutes Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Publié le 09/04/2026 à 22:00, il y a 1 heure 37 minutes Invitation - First Quarter 2026 Trading Update Conference Call
Publié le 09/04/2026 à 21:01, il y a 2 heures 36 minutes GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Publié le 09/04/2026 à 21:01, il y a 2 heures 36 minutes GEVELOT S.A.: COMMUNIQUE ARRETE DES COMPTES 2025
Publié le 09/04/2026 à 20:03, il y a 3 heures 34 minutes Annual General Meeting approves all proposals
Publié le 09/04/2026 à 18:45, il y a 4 heures 52 minutes EUROPLASMA: Tirage de 200 obligations convertibles en actions nouvelles pour un montant nominal de 1M€